Literature DB >> 34238737

[MiR- 4719 inhibits migration and invasion of human breast cancer cells via targeting ARHGAP36].

Q Li1, Y Qiu1, T Jin1, M Liu1, Y Hou2.   

Abstract

OBJECTIVE: To detect the expression of miR-4719 in breast cancer tissues and cells and explore its role in regulating invasion and migration of breast cancer cells.
OBJECTIVE: qRT-PCR was used to detect the expression of miR-4719 and ARHGAP36 in 30 pairs of human breast cancer tissues and adjacent tissues, two breast cancer cell lines (BT549 and MDA-MB- 231) and normal breast cells (MCF-10A). Bioinformatic methods were utilized to analyze the relationship between miR-4719 expression and overall survival of breast cancer patients and predict the potential target gene miR- 4719. miR-4719 mimics, ARHGAP36 shRNA and ARHGAP36 plasmids were transfected into breast cancer cells to test the effects of miR-4719 overexpression, ARHGAP36 knockdown and ARHGAP36 overexpression on cell migration and invasion using wound healing assay and Transwell assay. A dual-luciferase reporter assay was used to verify the direct binding between miR-4719 and 3'-UTR of ARHGAP36.
OBJECTIVE: Compared with those in adjacent tissues or normal breast cells, the expressions of miR-4719 were significantly decreased and the expression of ARHGAP36 was increased in breast cancer tissues (P < 0.001) and breast cancer cell lines (P < 0.01). A low expression of miR-4719 was correlated with a poorer overall survival of breast cancer patients (P < 0.05). Overexpression of miR-4719 and ARHGAP36 knockdown both significantly attenuated the invasion and migration abilities of breast cancer cells (P < 0.05). The expression of miR-4719 was inversely correlated to that of ARHGAP36 in breast cancer tissues (P < 0.01). Dual-luciferase reporter assay confirmed that ARHGAP36 was the target gene of miR-4719 (P < 0.01), and exogenous miR-4719 could significantly lower the expression of ARHGAP36 (P < 0.05). ARHGAP36 overexpression significantly reversed the inhibitory effects of miR-4719 mimics on migration and invasion of breast cancer cells (P < 0.05).
OBJECTIVE: The expression of miR-4719 is aberrantly decreased in breast cancer tissues to promote migration and invasion of breast cancer cells by up-regulating ARHGAP36 expression.

Entities:  

Keywords:  ARHGAP36; breast cancer; invasion; miR-4719; migration

Mesh:

Substances:

Year:  2021        PMID: 34238737      PMCID: PMC8267991          DOI: 10.12122/j.issn.1673-4254.2021.06.07

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  31 in total

Review 1.  miRNA dysregulation in breast cancer.

Authors:  Laoighse Mulrane; Sharon F McGee; William M Gallagher; Darran P O'Connor
Journal:  Cancer Res       Date:  2013-11-07       Impact factor: 12.701

2.  ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis.

Authors:  Yan Chen; Bo Zhang; Lei Bao; Lai Jin; Mingming Yang; Yan Peng; Ashwani Kumar; Jennifer E Wang; Chenliang Wang; Xuan Zou; Chao Xing; Yingfei Wang; Weibo Luo
Journal:  J Clin Invest       Date:  2018-04-09       Impact factor: 14.808

3.  Tumor Suppressor miRNA-204-5p Regulates Growth, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.

Authors:  Bok Sil Hong; Han Suk Ryu; Namshin Kim; Jisun Kim; Eunshin Lee; Hyunhye Moon; Kyoung Hyoun Kim; Min-Sun Jin; Nam Hoon Kwon; Sunghoon Kim; Donghyun Kim; Doo Hyun Chung; Kyeonghun Jeong; Kwangsoo Kim; Ki Yoon Kim; Han-Byoel Lee; Wonshik Han; Jihui Yun; Jong-Il Kim; Dong-Young Noh; Hyeong-Gon Moon
Journal:  Cancer Res       Date:  2019-02-08       Impact factor: 12.701

Review 4.  RNA therapy: Are we using the right molecules?

Authors:  Ai-Ming Yu; Chao Jian; Allan H Yu; Mei-Juan Tu
Journal:  Pharmacol Ther       Date:  2018-12-04       Impact factor: 12.310

5.  MicroRNA expression profiles classify human cancers.

Authors:  Jun Lu; Gad Getz; Eric A Miska; Ezequiel Alvarez-Saavedra; Justin Lamb; David Peck; Alejandro Sweet-Cordero; Benjamin L Ebert; Raymond H Mak; Adolfo A Ferrando; James R Downing; Tyler Jacks; H Robert Horvitz; Todd R Golub
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

6.  Silencing ARHGAP9 correlates with the risk of breast cancer and inhibits the proliferation, migration, and invasion of breast cancer.

Authors:  Tianyi Wang; Minwen Ha
Journal:  J Cell Biochem       Date:  2018-06-15       Impact factor: 4.429

7.  miR-221-3p promotes hepatocellular carcinogenesis by downregulating O6-methylguanine-DNA methyltransferase.

Authors:  Zushun Chen; Bangde Xiang; Lunan Qi; Shaoliang Zhu; Lequn Li
Journal:  Cancer Biol Ther       Date:  2020-10-06       Impact factor: 4.742

8.  MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.

Authors:  Liangliang Ren; Han Chen; Junwei Song; Xuhong Chen; Chun Lin; Xiaolan Zhang; Ning Hou; Jinyuan Pan; Zhongqiu Zhou; Lan Wang; Danping Huang; Jianan Yang; Yingying Liang; Jun Li; Hongbiao Huang; Lili Jiang
Journal:  Theranostics       Date:  2019-01-01       Impact factor: 11.556

Review 9.  Systems biology-based investigation of cooperating microRNAs as monotherapy or adjuvant therapy in cancer.

Authors:  Xin Lai; Martin Eberhardt; Ulf Schmitz; Julio Vera
Journal:  Nucleic Acids Res       Date:  2019-09-05       Impact factor: 16.971

Review 10.  Effect of exosomal miRNA on cancer biology and clinical applications.

Authors:  Zhenqiang Sun; Ke Shi; Shuaixi Yang; Jinbo Liu; Quanbo Zhou; Guixian Wang; Junmin Song; Zhen Li; Zhiyong Zhang; Weitang Yuan
Journal:  Mol Cancer       Date:  2018-10-11       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.